SEC Form 4 · accession 0001123292-15-000970

FIVE PRIME THERAPEUTICS INC · FPRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP & Chief Business Officer · Director

Period of report

Jun 24, 2015

Accepted (ET)

Jun 26, 2015 · 5:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001175505

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jun 24, 2015	M	3,557	$5.54	A	49,365	D
Common Stock	Jun 24, 2015	M	15,921	$8.49	A	65,286	D
Common Stock	Jun 24, 2015	M	10,347	$8.49	A	75,633	D
Common Stock	Jun 24, 2015	M	6,471	$11.14	A	82,104	D
Common Stock	Jun 24, 2015	M	1,788	$6.89	A	83,892	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1	$5.54	Jun 24, 2015	M	3,557	D	—	Jul 15, 2022	Common Stock	3,557	46,616	D
Employee Stock Option (right to buy)^F2	$8.49	Jun 24, 2015	M	15,921	D	—	Jul 13, 2021	Common Stock	15,921	339	D
Employee Stock Option (right to buy)^F3	$8.49	Jun 24, 2015	M	10,347	D	—	Jan 1, 2022	Common Stock	10,347	6,644	D
Employee Stock Option (right to buy)^F4	$11.14	Jun 24, 2015	M	6,471	D	—	Aug 21, 2024	Common Stock	6,471	43,529	D
Employee Stock Option (right to buy)^F5	$6.89	Jun 24, 2015	M	1,788	D	—	Jul 28, 2020	Common Stock	1,788	0	D

F1This option began vesting on July 12, 2012, at a rate of 1/48th per month.
F2This option began vesting on July 14, 2011, at a rate of 1/48th per month.
F3This option began vesting on January 2, 2012, at a rate of 1/48th per month.
F4This option began vesting on September 22, 2014, at a rate of 1/48th per month.
F5This option is fully vested and immediately exercisable.